Becton Dickinson to invest $30M in IV production capacity
Becton Dickinson (NYSE:BDX) said it plans to make additional investments in its U.S. manufacturing network to add capacity ...
Taiwan News3d
Regeneron Provides Business Updates and Highlights from Broad Clinical Pipeline at the 43rd Annual J.P. Morgan Healthcare Conference
EYLEA HD® and EYLEA® remained the U.S. anti-VEGF category leader in 2024; aggregate U.S. net product sales were $6 billion for full-year 2024, up 1% based on preliminary (unaudited) results EYLEA HD ...
Taiwan News10d
Vietnam Needle-free Injection System Market Research Covers, Future Trends and Opportunities, Past, Present Data, and Deep Analysis
Request To Download Free Sample of This Strategic Report @ This country research report on Vietnam Needle-free Injection System Market offers comprehensive insights into the market landscape, ...
GitHub19d
The extra fast DI (Dependency Injection) library running on Unity Game Engine.
"V" means making Unity's initial "U" more thinner and solid ... ! In this example, the routeSearch of CharacterService is automatically set as the instance of AStarRouteSearch when CharacterService is ...
India Today19d
IIT Bombay designs needle-free shock syringe for painless injections
IIT Bombay has developed needle-free shock syringes for painless, safe drug delivery, offering hope for a future without injection-related trauma ... The device, about the size of a ballpoint pen, is ...
Business Wire19d
Takeda Announces Approval of HYQVIA® 10% S.C. (Subcutaneous) Injection Set in Japan for Patients with Agammaglobulinemia or Hypogammaglobulinemia
HYQVIA is the first plasma-derived therapy for subcutaneous injection in Japan that consists of a combination of one vial of Immunoglobulin 10% and one vial of Recombinant Human Hyaluronidase PH20 ...
Hindustan Times19d
IIT Bombay team develops needle-free syringe for painless injections
By applying the principles of shock-wave dynamics, we can design needle-free drug delivery systems that not only overcome the trauma associated with traditional injections but also pave the way ...
Healio20d
FDA approves Opdivo as subcutaneous injection
The FDA has approved nivolumab and hyaluronidase-nvhy for subcutaneous injection in adults with solid tumors in which nivolumab is indicated, according to a press release. Nivolumab and ...
Targeted Oncology20d
FDA Approves Subcutaneous Nivolumab Across Existing Solid Tumor Indications
The FDA has approved the subcutaneous formulation of nivolumab (Opdivo). This approval makes it the first and only subcutaneously administered PD-1 inhibitor. Subcutaneous nivolumab is approved in all ...